Erweiterte Suche

Zurzeit ist Gerard Florian Group Executive-Technology bei der Australia & New Zealand Banking Group Ltd. In seiner früheren Laufbahn hatte Herr Florian die Position des Chief Strategy Officer bei Dimension Data Australia Pty Ltd. inne.

Florian Pape is the founder of Argos GmbH, which was founded in 2001.
He is currently the Chairman-Supervisory Board at BPT Building & Power Technology Holding AG, Co-Managing Director at BTS Building Technology & Service GmbH, Member-Supervisory Board at Arthur Flury AG, and Principal at Ascent Capital Africa Ltd.
Mr. Pape's former positions include Managing Director at Active Equity Management GmbH from 2002 to 2008 and Partner at Orlando Management AG from 2000 to 2014.
Mr. Pape's education includes an MBA from Stanford University, an undergraduate degree from the University of Wisconsin, and an undergraduate degree from the University of Hannover.

John D.
Florian worked as the Chief Financial Officer-North America at Emerson Radio Corp..
Mr. Florian attended William Paterson University for his undergraduate degree.

Florian Schönharting is the founder of ACADIA Pharmaceuticals, Inc. (founded in 1993), Genmab A (founded in 1999), Nordic Biotech Advisors ApS (founded in 2001), Forward Pharma A (founded in 2005), and GH Research Plc (founded in 2018).
He holds the title of Chief Executive Officer at Nordic Biotech Advisors ApS and Chairman at Forward Pharma A and GH Research Plc.
Mr. Schönharting is also the founder of Zealand Pharma A and Life Cycle Pharma A.
Mr. Schönharting's current job(s) include Chairman at GH Research Ireland Ltd., Director at Danish Corporate Governance Association, and Manager at Tech Growth Invest ApS.
Mr. Schönharting's former job(s) include Director at Osteologix, Inc., Rose Pharma A, Osteologix Holdings Plc, Spree Pharma A, Blue Note Pharmaceuticals BV, and Aditech Pharma AB.
Mr. Schönharting's education history includes graduating from Copenhagen Business School.

Florian Fischer is the founder of MedVenture Partners GmbH, which was founded in 2002.
He held the position of Managing Director from 2002 to 2020.
Dr. Fischer also held former positions at AbCheck sro, Amphivena Therapeutics, Inc., Deutsche Bank AG, Affimed NV, KPMG LLP, Affimed NV Niederlassung Deutschland, Vivendy Therapeutics Ltd., and Vectura GmbH.
Dr. Fischer's education includes a doctorate from the University of Bielefeld and an undergraduate degree from Humboldt-Universität zu Berlin.